<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34277157</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2168-8184</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cureus</Title>
          <ISOAbbreviation>Cureus</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evans Syndrome in a Jehovah's Witness.</ArticleTitle>
        <Pagination>
          <StartPage>e15508</StartPage>
          <MedlinePgn>e15508</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e15508</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.15508</ELocationID>
        <Abstract>
          <AbstractText>Evans syndrome (ES) is a rare hematologic disorder characterized by the development of autoimmune hemolytic anemia (AIHA), idiopathic thrombocytopenia, and occasionally immune-mediated neutropenia. Jehovah's Witnesses (JW) often decline blood product transfusion on the grounds of a scriptural stand based on biblical texts. The acute management of ES often consists of blood product transfusion in addition to high-dose steroids and intravenous immunoglobulin. We describe the case of a JW female presenting with new-onset, acutely worsening AIHA and thrombocytopenia with concern for hemodynamic compromise who was successfully treated with erythropoietin-stimulating agents, parenteral iron, folic acid, and high-dose steroids.</AbstractText>
          <CopyrightInformation>Copyright © 2021, Leonhardt et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Leonhardt</LastName>
            <ForeName>Lex P</ForeName>
            <Initials>LP</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine, Kettering Medical Center, Dayton, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pervez</LastName>
            <ForeName>Aamir</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine, Kettering Medical Center, Dayton, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calvo</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Hematology and Medical Oncology, Kettering Medical Center, Dayton, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cureus</MedlineTA>
        <NlmUniqueID>101596737</NlmUniqueID>
        <ISSNLinking>2168-8184</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">blood dyscrasia</Keyword>
        <Keyword MajorTopicYN="N">evans syndrome</Keyword>
        <Keyword MajorTopicYN="N">idiopathic thrombocytopenia</Keyword>
        <Keyword MajorTopicYN="N">jehovah's witness</Keyword>
        <Keyword MajorTopicYN="N">microangiopathic autoimmune hemolytic anemia</Keyword>
        <Keyword MajorTopicYN="N">thrombocytopenia</Keyword>
        <Keyword MajorTopicYN="N">transfusion refusal</Keyword>
      </KeywordList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>19</Day>
          <Hour>5</Hour>
          <Minute>57</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34277157</ArticleId>
        <ArticleId IdType="pmc">PMC8269972</ArticleId>
        <ArticleId IdType="doi">10.7759/cureus.15508</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Evans' syndrome: from diagnosis to treatment. Audia S, Grienay N, Mounier M, Michel M, Bonnotte B. J Clin Med. 2020;9:3851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7759819</ArticleId>
            <ArticleId IdType="pubmed">33260979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Management of Evans syndrome. Norton A, Roberts I. Br J Haematol. 2006;132:125–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16398647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans' syndrome in adults: an observational multicentre study. Fattizzo B, Michel M, Giannotta JA, et al.  Blood. 2020;136:27–28.</Citation>
        </Reference>
        <Reference>
          <Citation>Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort. Hansen DL, Möller S, Andersen K, Gaist D, Frederiksen H. Am J Hematol. 2019;94:1081–1090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31292991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jehovah’s Witnesses and blood transfusion.  [Dec;2020 ];Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. https://www.transfusionguidelines.org/transfusion-handbook/12-management-of-patients-who-do-not-accept-transfusion/12-2-jehovah-s-witnesses-and-blood-transfusion JPAC, Transfusion Handbook. 2020 12.2:1–3.</Citation>
        </Reference>
        <Reference>
          <Citation>How do we treat life-threatening anemia in a Jehovah's Witness patient? Posluszny JA Jr, Napolitano LM. Transfusion. 2014;54:3026–3034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25330835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Transfusion replacement strategies in Jehovah's Witnesses and others who decline blood products. DeLoughery TG. https://www.hematologyandoncology.net/archives/december-2020/transfusion-replacement-strategies-in-jehovahs-witnesses-and-others-who-decline-blood-products/ Clin Adv Hematol Oncol. 2020;18:826–823.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33406059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. Arbach O, Funck R, Seibt F, Salama A. Transfus Med Hemother. 2012;39:221–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3375127</ArticleId>
            <ArticleId IdType="pubmed">22851939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>A case of pregnancy complicated with Evans syndrome with sequential development of autoimmune warm antibody hemolytic anemia and idiopathic thrombocytopenic purpura. Suzuki H, Yamanoi K, Ogura J, et al.  Case Rep Obstet Gynecol. 2019;2019:2093612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6348819</ArticleId>
            <ArticleId IdType="pubmed">30733882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans syndrome: clinical perspectives, biological insights and treatment modalities. Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D. J Blood Med. 2018;9:171–184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6190623</ArticleId>
            <ArticleId IdType="pubmed">30349415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Natural history, pathogenesis, and treatment of Evans syndrome in children. Mantadakis E, Farmaki E. J Pediatr Hematol Oncol. 2017;39:413–419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28654461</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
